Sphere Bio
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Sphere Bio (formerly known as Sphere Fluidics) became a brand of Fluidic Sciences Ltd following the acquisition of its business and assets in September 2025. The original company was founded as a Cambridge-based Life Sciences R&D company specializing in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation. The company's reported 25 patented products encompassing picodroplet-based microfluidic instruments Cyto-Mine and Cyto-Mine Chroma, biochips, and specialist chemicals was also transferred to Fluidic Sciences Ltd as part of the acquisition.
Sphere Bio (formerly known as Sphere Fluidics) became a brand of Fluidic Sciences Ltd following the acquisition of its business and assets in September 2025. The original company was founded as a Cambridge-based Life Sciences R&D company specializing in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation. The company's reported 25 patented products encompassing picodroplet-based microfluidic instruments Cyto-Mine and Cyto-Mine Chroma, biochips, and specialist chemicals was also transferred to Fluidic Sciences Ltd as part of the acquisition.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359511935 under CC BY-SA 4.0; modifications have been made.